Cushing's disease patients
Update on medical treatment for Cushing’s disease
... 162 patients were adminis- tered 600 or 900 μg of pasireotide twice daily, with dose escalations of 300 μg made after 3 months, depending on UFC ...of patients in the 600 μg group and 25 % in the 900 μg ...
13
<p>Circulating Irisin Levels as a Marker of Osteosarcopenic-Obesity in Cushing’s Disease</p>
... in patients with CD, till ...in patients with active CD compared to control subjects and con- trolled CD, showing that hypercortisolism and related comorbidities induce a decrease of circulating irisin ...
10
Microscopic versus endoscopic transsphenoidal surgery in the Leiden cohort treated for Cushing’s disease: surgical outcome, mortality, and complications
... ’ s disease ...25 patients per study group) have compared both the microscopic and endo- scopic techniques for treatment of Cushing ’ s disease per- formed in the same center [9 ...
15
Case report: ACTH-secreting pituitary carcinoma metastatic to the liver in a patient with a history of atypical pituitary adenoma and Cushing’s disease
... most patients receiving radiation already present with an aggressive clinical course, and the disease is rare enough that a ran- domized clinical trial is not possible to isolate the vari- able of radiation ...
8
Systemic therapy of Cushing’s syndrome
... a disease with high mortality and less alternatives compared to the anti-fungal indica- ...CS patients with hyperandrogenic symptoms as it also inhibits steroidogenesis of androgens (for instance in the ...
16
Clinical use of pasireotide for Cushing's disease in adults
... educate patients to make the necessary lifestyle changes, modify their diet, and get more ...In patients with evidence of insulin resistance, medical treatment should begin with met- formin as the ...
10
<p>The relationship of mitochondrial dysfunction and the development of insulin resistance in Cushing’s syndrome</p>
... of patients with active Cushing ’ s syndrome was increased with a tendency to decrease toward normal levels after the successful ...in patients with active Cushing ’ s syndrome ...
13
A pitfall of bilateral inferior petrosal sinus sampling in cyclic Cushing’s syndrome
... 65 patients with cyclic CS, pituitary tumors accounted for 54%, followed by ectopic (26%) and adrenocortical tumors ...of patients with CS secondary to ectopic tumors, an ectopic source of ...
6
Hypertension and other morbidities with Cushing’s syndrome associated with corticosteroids: a review
... cases, patients should be treated for corticosteroid-related morbidi- ...in patients who require long-term corti- costeroid treatment and develop weakness during ...that patients with CS should be ...
10
A case of autonomous cortisol secretion in a patient with subclinical Cushing’s syndrome, GNAS mutation, and paradoxical cortisol response to dexamethasone
... subclinical Cushing ’ s syndrome during an evaluation for bilateral adrenal ...in patients with pigmented nodular adrenocortical disease or Carney ...for patients with this type of ...
8
Low immediate postoperative serum-cortisol nadir predicts the short-term, but not long-term, remission after pituitary surgery for Cushing’s disease
... all patients undergoing transsphenoidal ...Cushing’s disease, we have chosen to withhold glucocorticoids and followed the clinical condition closely, while measuring S-cortisol every sixth hour to ...
9
Cushing's syndrome: epidemiology and developments in disease management
... initiation of treatment. Causes of death included suicide (n = 1), cardiac rupture (n = 1), stroke (n = 1), and severe infec- tions (n = 3; peritonitis, septicemia, and pneumonia). The cause of death could not be ...
13
Medical treatment of Cushing's disease: Overview and recent findings
... Cushing’s disease remains suboptimal and should be reserved for patients with recurrent or refractory Cushing’s, unfit for pituitary surgery, stereotactic radiosurgery or for management of preoperative ...
9
ACTH-independent Cushing’s syndrome with bilateral cortisol-secreting adrenal adenomas: a case report and review of literatures
... The optimal treatment for patients with bilateral cortisol-secreting adenomas remains uncertain [27, 38]. Two-step bilateral adrenalectomy was performed on our patient and resulted in remarkable remission of ...
8
Articles
... • Isaia M, Milano F, Mammola S (2016) Threatening the giant: the response of Vesubia jugorum (Araneae, Lycosidae) to climate change. In: Cushing P (Ed.) Program and Abstracts[r] ...
15
Disease-related information requirements in patients with Crohn’s disease
... was used to evaluate the information demands of patients with CD and revised by our group for the needs of the Chinese patients by adding accessible information concerning Chinese medicine treatments. The ...
8
Original Article Changes and significance of peripheral blood helper T cell 9 and interleukin-9 in patients with chronic obstructive pulmonary disease
... COPD patients is significantly elevated, especially in the cytoplasm of macrophages, and IL-9 may be involved in COPD airway inflammation and injury through the macrophages ...the patients in Group AECOPD, ...
7
Pituicytoma Associated with Serum Adrenocorticotropic Hormone Elevation
... as Cushing disease ...of Cushing disease were ...with Cushing disease, histopathological examina- tion revealed pituicytoma with Crooke’s cells ...
6
High Resolution MR Imaging of Microadenomas at 1 5 T: Experience with Cushing Disease
... TABLE 3: MR Observations in Surgically Verified Cushing Adenoma Finding Mean size range of adenoma in mm: MR Surgery Stalk deviation : Contralateral Midline Ipsilateral Sloped sellar flo[r] ...
7
Effects of corticotropin releasing hormone and dexamethasone on proopiomelanocortin messenger RNA level in human corticotroph adenoma cells in vitro
... nonadenomatous tissues were examined in four patients. Human POMC mRNA in the cells was analyzed by Northern blot hybridization. Human POMC DNA probe hybridized with only a single size class of RNA (approximately ...
6